Close mobile menu×
Close mobile menu

Nancy S. Green, MD

Board Certifications: 
Pediatric Hematology-Oncology, Pediatrics
Expertise in: 
Cancer Care
Accepting New Patients
Treats Children
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 
(212) 305-9770

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Pediatric Hematology-Oncology
  • Pediatrics

Clinical Expertise

  • Cancer Care
  • Benign Hematology
  • Newborn Screening
  • Sickle Cell Anemia

Specialties

Education & Training

  • Columbia University College of Physicians and Surgeons
  • Internship: Columbia Presbyterian Medical Center, NY
  • Residency: Columbia Presbyterian Medical Center, NY
  • Fellowship: Columbia Presbyterian Medical Center, NY

About Nancy Green

Nancy Green, MD is a pediatric hematologist with expertise in the diagnosis and treatment of the full-range of pediatric blood disorders, with a special interest in hemoglobinopathies such as sickle cell disease.

Her interest in sickle cell disease began while in college, where Dr. Green was attracted to its clinical complexity, laboratory features, and research opportunities to improve the health of people with the disease. Her current research focuses on optimizing treatments for sickle cell disease, especially the drug hydroxyurea - the primary therapy for patients. She is studying the differences among patients in their response to this drug: the genetics of response to hydroxyurea, adherence to therapy, and cultural and other aspects. She is also studying the hematologic aspects of bone marrow transplantation, which can cure sickle cell disease but is not an option for many patients.

Dr. Green hopes to contribute to the field by enhancing the understanding of how patients with sickle cell disease respond to hydroxyurea, with the goal of clarifying how it can be most effectively used and by whom. For families whose children do not respond well to this drug, she hopes her work will help them as they think about their options for treatment.

Dr. Green's research also focuses on newborn screening, a public health program in which infants are tested for a variety of disorders usually before the baby goes home from the newborn nursery. Screening is a service provided for every baby born in the United States and elsewhere. Its goal is to identify babies affected by conditions and to start treatment early to help keep them healthy. One of the conditions included in newborn screening is sickle cell disease. Other blood diseases may be identified by screening newborns or young children.

Academic Titles

  • Professor of Pediatrics at CUMC

Administrative Positions

  • Associate Dean for Academic Operations
  • Associate Director, Irving Institute for Clinical and Translational Research

Hospital Affiliations

  • NewYork-Presbyterian/Morgan Stanley Children's Hospital
  • NewYork-Presbyterian/Columbia

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
161 Fort Washington Avenue
New York, New York 10032
Phone:
(212) 305-9770
Fax:
(212) 305-8408
Primary

Research

Grants

HYDROXYUREA ADHERENCE FOR PERSONAL BEST IN SICKLE CELL TREATMENT (Federal Gov)

Sep 27 2017 - Jun 30 2021

CLINICAL AND TRANSLATIONAL SCIENCE AWARD (Federal Gov)

Jul 1 2016 - May 31 2021

BURDEN AND REDUCING RISK OF NEUROLOGICAL, COGNITIVE AND BEHAVIORAL IMPAIRMENT OF PEDIATRIC SICKLE CELL DISEASE IN UGANDA (Federal Gov)

Aug 18 2016 - Jul 31 2019

NORTHEAST REGION SICKLE CELL DISEASE TREATMENT DEMONSTRATION REGIONAL COLLABORATIVE PROGRAM (Federal Gov)

Sep 1 2017 - Aug 31 2018

HRSA MCHB SUPPORT TO THE ACHDNC TO2 (Federal Gov)

Sep 1 2016 - Jun 30 2018

CENTER FOR RESEARCH ON ETHICAL, LEGAL AND SOCIAL IMPLICATIONS OF PSYCHIATRIC, NEUROLOGIC AND BEHAVIORAL GENETICS (Federal Gov)

May 3 2013 - May 31 2018

THE PRO-INFLAMMATORY EFFECTS OF ACUTE EXERCISE IN CHILDREN WITH SCA (Federal Gov)

Apr 1 2017 - Mar 31 2018

PK & RELATIVE BIOAVAILABILITY OF A LIQUID FORMULATION OF HYDROXYUREA IN PEDIATRIC PATIENTS WITH SICKLE CELL ANEMIA (Federal Gov)

Apr 15 2011 - Sep 29 2017

EVIDENCE-BASED REVIEWS AND RELATED MEDICAL ANALYSIS ACTIVITIES FOR SECRETARY S DISCRETIONAY ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN (Federal Gov)

Sep 15 2015 - Mar 14 2017

TRANSITION READINESS ASSESSMENT OF PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE TO ADULT CARE AT THE SICKLE CELL CLINIC IN KUMASI, GHANA (Private)

Jun 1 2016 - Aug 15 2016

CLINICAL AND TRANSLATIONAL SCIENCE AWARD (UL1) (Federal Gov)

Sep 30 2006 - Jun 30 2016

HYDROXYUREA ADHERENCE FOR PERSONAL BEST IN SICKLE CELL TREATMENT: HABIT (Federal Gov)

May 8 2013 - Apr 30 2016

HYDROXYUREA TO PREVENT CNS COMPLICATIONS OF SICKLE CELL DISEASE IN CHILDREN (Federal Gov)

Dec 1 2014 - Jul 31 2015

EVIDENCE-BASED REVIEWS FOR THE DISCRETIONARY ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN (DACHDNC) (Federal Gov)

Jul 24 2014 - Jul 23 2015

HEALTH RESOURCES AND SERVICES ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES SECRETARY S ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN AND NEWBORN SCREENING AND EARLY CHILDHOOD SCREENING PROGRAMS, CONTRACT NUMBER HHSH2502012 (Federal Gov)

Oct 1 2013 - May 31 2014

CENTER FOR ELSI RESEARCH ON PSYCHIATRIC, NEUROLOGIC, AND BEHAVIORAL GENETICS (Federal Gov)

Jun 1 2010 - Apr 30 2014

HERITABLE DISORDERS IN NEWBORNS AND CHILDREN AND NEWBORN SCREENING AND EARLY CHILDHOOD SCREENING PROGRAMS (Federal Gov)

Oct 1 2012 - Sep 27 2013

HRSA: HERITABLE DISORDERS & GENETIC DISEASES IN NEWBORNS & E ARLY CHILDHOOD SCREENING PROGRAMS (Federal Gov)

Jul 1 2008 - Aug 18 2012

GENETIC SERVICES PROJECT - SICKLE CELL MEDICAL HOMES FOR HAR LEM & NORTHERN MANHATTAN (Federal Gov)

Jun 1 2008 - Dec 31 2011

DUKE CLINICAL AND TRANSLATIONA L SCIENCE INST (Private)

Oct 1 2008 - Jun 30 2011